Lifecore Biomedical Inc (LFCR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 05/31
| 08-2014 | 05-2014 | 02-2014 | 11-2013 | 08-2013 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 2,424 | N/A | 14,726 | 8,304 | 4,811 |
| Depreciation Amortization | 1,513 | N/A | 5,364 | 3,787 | 1,842 |
| Income taxes - deferred | 429 | N/A | 5,286 | 4,050 | 2,303 |
| Accounts receivable | 929 | N/A | -4,487 | -5,133 | 3,565 |
| Accounts payable and accrued liabilities | 5,264 | N/A | -2,522 | 2,505 | -2,876 |
| Other Working Capital | -621 | N/A | -2,855 | -4,736 | 658 |
| Other Operating Activity | -5,995 | 0 | -1,678 | -4,484 | -5,765 |
| Operating Cash Flow | $3,943 | $N/A | $13,834 | $4,293 | $4,538 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | 1,545 | 1,545 | 248 |
| PPE Investments | -4,098 | N/A | -10,192 | -7,681 | -4,345 |
| Purchase Of Investment | -11,000 | N/A | N/A | N/A | N/A |
| Investing Cash Flow | $-15,098 | $N/A | $-8,647 | $-6,136 | $-4,097 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 11,117 | N/A | 3,500 | N/A | 0 |
| Debt Issued | 7,070 | N/A | N/A | N/A | N/A |
| Debt Repayment | -1,411 | N/A | -4,525 | -3,128 | -1,383 |
| Common Stock Issued | 3 | N/A | 2,147 | 1,253 | 250 |
| Other Financing Activity | -11,338 | 0 | -7,040 | -4,234 | -4,129 |
| Financing Cash Flow | $5,441 | $N/A | $-5,918 | $-6,109 | $-5,262 |
| Beginning Cash Position | 14,243 | N/A | 13,718 | 13,718 | 13,718 |
| End Cash Position | 8,529 | N/A | 12,987 | 5,766 | 8,897 |
| Net Cash Flow | $-5,714 | $N/A | $-731 | $-7,952 | $-4,821 |
| Free Cash Flow | |||||
| Operating Cash Flow | 3,943 | N/A | 13,834 | 4,293 | 4,538 |
| Capital Expenditure | -4,098 | N/A | -10,192 | -7,681 | -4,345 |
| Free Cash Flow | -155 | 0 | 3,642 | -3,388 | 193 |